Pharmaco - Press Releases

Date	Title	Company
15-Dec-2021	Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH	Dermapharm Holding SE
15-Dec-2021	RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Active Psoriatic Arthritis	AbbVie
15-Dec-2021	Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation	Sanofi
15-Dec-2021	Roche’s Polivy combination reduced the risk of disease worsening or death by 27% in people with previously untreated aggressive form of lymphoma	Roche
15-Dec-2021	Mirikizumab Demonstrates Superiority over Placebo in Phase 3 Maintenance Study in Ulcerative Colitis, Supporting Regulatory Submissions in 2022	Lilly
15-Dec-2021	Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401	Bristol Myers Squibb
15-Dec-2021	PFIZER ANNOUNCES ADDITIONAL PHASE 2/3 STUDY RESULTS CONFIRMING ROBUST EFFICACY OF NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE IN REDUCING RISK OF HOSPITALIZATION OR DEATH	Pfizer
15-Dec-2021	XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips	XPhyto Therapeutics Corp.
15-Dec-2021	SciRhom Establishes a World-Class Clinical Advisory Board	B3C newswire
15-Dec-2021	Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin	Polyphor AG
15-Dec-2021	Relief Reports that U.S. Collaboration Partner Announces New, Favorable Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19	RELIEF THERAPEUTICS Holding AG
14-Dec-2021	Medacta Launches 360° (Anterior and Posterior) Cervical Platform, Highlighting MySpine Cervical, a Further Enhancement to the MySolutions Personalized Ecosystem	Medacta Group SA
14-Dec-2021	Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office	Medios AG
14-Dec-2021	sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma	sterna biologicals GmbH & Co. KG
14-Dec-2021	Pfizer to Acquire Arena Pharmaceuticals	Pfizer
14-Dec-2021	Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform	Lilly
14-Dec-2021	MS Pharma becomes Partner for the Commercialization of FYB201, Formycon's Biosimilar Candidate to Lucentis(R)1 (ranibizumab), in the MENA Region	Formycon AG
14-Dec-2021	APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rights	APONTIS PHARMA AG
14-Dec-2021	Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer	Epigenomics AG
14-Dec-2021	Biotest AG: Biotest treats first CMV-positive pregnant woman in Phase III clinical trial to prevent transmission of CMV infection to the unborn child	Biotest AG